Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Meet a leader in the plant-based foods, courting millions in inflows

As food security becomes more crucial, ensuring companies can grow their business as well as they grow their products is more important than ever.Focused on high-growth companies in the agribusine...
Jonathon Brown | July 25, 2022 |

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...
Streetwise Reports | December 27, 2019 |

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...
Streetwise Reports | August 28, 2019 |

The Dales Report panelists agree on this vote: Way to go, Ohio

Welcome to the Trade To Black podcast on Stockhouse.com . In the episode in the above video, Shadd Dales, Anthony Varrell and Benjamin Smith talk in-depth about the following stories and more: Ohio voters approve the legalization of adult use cannabis ...
The Dales Report | November 9, 2023 |

The fragile state of global PGM supply

On demand side, the global economic recession caused platinum demand in the car and jewelry sectors to enter a cyclical downturn. However, a substantial supply reduction due to the labour strife in South Africa moved the platinum market from surplus to deficit over the cours...
Leo Liu, MBA, CFA | November 26, 2012 |

Nickel surplus to be diminished by Indonesian export ban

Why does nickel continue to be in great demand? The simple answer is that nickel has better corrosion resistance, better toughness and better strength at high and low temperatures than other metals, as well as a range of special magnetic and electronic properties. It is also...
Leo Liu, MBA, CFA | October 28, 2012 |

Growing Rapidly and Efficiently in California's Cannabis Market

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Omri Wallach was recently joined live by Arni ...
Omri Wallach | September 30, 2019 |

PODCAST: How this Cannabis Co. is Creating a Self-Contained Ecosystem

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Dave Jackson was recently joined live by Arni ...
Dave Jackson | August 21, 2019 |

Oil & Gas Explorer Proves Up Exciting Measured Oil and Gas Production from Orogrande Basin Project

Discovering a new oil field is a major accomplishment. But effectively producing hydrocarbons from that field is seen as a truly exceptional, massive success. As you can probably imagine, it's a rare occurrence. So, when a small oil and gas exploration company reaches...
Streetwise Reports | February 26, 2020 |

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. This...
Streetwise Reports | January 9, 2020 |
1 2 3 4 5 6 7 8